FutureWorld (FWDG) CB Scientific Announces Test4 Distribution Agreement

Company Signs U.S. Distribution Agreement for Test4 Cannabis THC & CBD Detection Kits

St. Petersburg, Florida, UNITED STATES

Denver, Colorado, Aug. 10, 2015 (GLOBE NEWSWIRE) -- FutureWorld Corp. (OTC: FWDG), a cannabis technology accelerator and a leading provider of advanced technologies and solutions to the global cannabis industry, announces today that its subsidiary, CB Scientific, has signed a distribution agreement with Advanced Ethnobotanical Developments for the U.S.  

Advanced Ethnobotanical Developments became a distributor for their Test4 line of PersonalAnalytics -CBD& THC Combo and Edibles Detection Kits. 

Under the terms of the agreement, Advanced Ethnobotanical Developments will be a U.S. distributor for the Test4 line of PersonalAnalytics from CB Scientific, including the - CBD&THC Combo and Edibles Detection Kits. The Test4 product line is designed for Personal Analytics and complements CB Scientific's other test products such as the Test4CBD, Test4THC, Test4Combo and Test4Edibles. The combination of Advanced Ethnobotanical Developments and CB Scientific detection solutions allows Advanced Ethnobotanical Developments to provide customers with a complete range of CBD and THC detection products.

"Advanced Ethnobotanical Developments is committed to providing vendor solutions that fulfill users and patients' testing kit needs across the cannabis market," said Jeremiah Degilio, owner and general manager of Advanced Ethnobotanical Developments.  "PersonalAnalytics line of Test Kits are in critical need for many family members and patients, and offering the Test4 line for home use will provide additional choices for our customers. CB Scientific shares our commitment to innovation and high-quality products that help improve parents' lives."Never again question if there is actually THC or CBD present in any product. If the cannabinoids you are searching for are present, PERSONALANALYTICS will detect it. Test4 Detection Kits are quick, easy, and effective.

SIMPLE, SMART and ACCURATE with clear to understand detection process.

Henry Biza, CEO of CB Scientific added, " Advanced Ethnobotanical Developments is a great partner for the Test4 brand. They have the scale, infrastructure, reputation, cannabis experience and complementary product portfolio to make CB Scientific's Test4 products a market leader in the United States. We are happy that Advanced Ethnobotanical Developments recognized the quality, quality, innovation and design quality of our Test4 line products."

The distribution agreement may be expanded with additional products and territories in the future. Financial terms of the agreement were not disclosed.  

To order online please visit;  http://www.test4cbd.com/shop

To request distributorship opportunities or to sell wholesale, please contact; sales@cbscientific.com. 

About Advanced Ethnobotanical Developments

Advanced Ethnobotanical Developments is a global corporation serving the hemp and cannabis industry with products and services that help parents measurably improve the safety and quality of care.  More information may be found at http://www.usacbdoilwholesale.com.

About CB Scientific

CB Scientific (www.cbscientific.com) is a wholly owned subsidiary of FutureWorld Corp based in Denver, Colorado. CB Scientific is continuing to develop new technologies specifically for cannabis (hemp) analytics. CB Scientific believes every product sold to patients as "Medical Quality" should be inspected for health benefits, safety, consistency, purity, potency and packaged properly for distribution. CB Scientific has worked with many of the cannabis industry leaders in the country and have also been featured in cannabis industry publications including High Times Magazine, Culture and many trade publications, on-air interviews and panel discussions across the United States. CB Scientific's focus has been the education and safety of consumers combined with innovation to put power into the hands of the patients. Values that FutureWorld is pleased to embrace while ever striving to raise the bar of cannabis analytics even higher.

The test kits have been featured on ABC, CBS, Fox, Telemundo, The Adam Dunn Show, as well as in publications such as High Times, Culture and Forbes Magazine. In December 2014, just 94 days after its launch the THC & CBD Test Kits were awarded "Product of the Year" by the Cannabis Business Awards in Colorado.

To request further information about CB Scientific, please email us at info@cbscientific.com, log onto our website at http://www.cbscientific.com or visit us on Twitter @cbscientific.

About FutureWorld Corp.

FutureWorld (OTC: FWDG), a Delaware corporation, is a leading provider of advanced technologies and solutions to the global cannabis industry. FutureWorld, together with its subsidiaries, focuses on the identification, acquisition, development, and commercialization of cannabis related products and services, such as industrial Hemp. FutureWorld, through its subsidiaries, provides personal and professional THC and CBD test kits, pharmaceutical grade CBD oil solutions, SafeVape vaporizers, smart sensor technology, communication network, surveillance security, data analysis for smart cultivation and consultation for the industrial hemp and legal medicinal cannabis. Our wireless agricultural smart sensor networks offer precision to the agriculture, irrigation systems, and greenhouses for the global cannabis and hemp industry. FutureWorld and its subsidiaries do not grow, distribute or sell marijuana. As the only Cannabis Technology Accelerator, FutureWorld will incubate and fund leading technologies, products, and services for Cannabis industry (Industrial Hemp) for foreseeable future; bringing value to its core and its shareholders.

To request further information about FutureWorld, please email us at info@futureworldcorp.com, log onto our website at http://www.futureworldcorp.com or visit us at our Facebook page facebook.com/futureworldenergy or on Twitter @futureworldinc.

Forward-Looking Statements

This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words "plan," "expect," "believe," and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets. This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.